Funding · Company
Memento Medicines, Inc.
Boston, MABiotech & Pharma
Memento Medicines, Inc. of Boston, MA has disclosed $38M across 1 Form D offering filed with the SEC on Jun 16, 2026.
$38M
Total disclosed
1
Form D offering
2025
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$38M
Form D · Jun 16, 2026 ↗
Q2 2026
· target $93M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2025SEC CIK0002139514Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →